Back to Agenda
NCA Showcase: Brexit Implications for the EU27 Network and Decentralised Activities
Session Chair(s)
Christa Wirthumer-Hoche, PhD
Retired, Austria
This session gives the floor to the National Competent Authorities (NCA) to discuss their local progress, burning topics, and stakeholder engagement regarding Brexit.
Speaker(s)
Brexit Implications for the HMA Multi-Annual Work Programme
Christa Wirthumer-Hoche, PhD
Retired, Austria
HMA Brexit Task Force
Hugo Hurts
Chair HMA Brexit Task Force; Executive Director, Medicines Evaluation Board (MEB), Netherlands
Focus on MRP/DCP
Laura Oliveira Santamaria, MPharm
Head of RRAA Division, Human Medicines Department, AEMPS, Spain
How is Industry Preparing?
Virginia Acha
AVP, Science and Regulatory Policy, Merck & Co., Inc., United Kingdom
Strengthening and Optimisation of Regulatory Procedures
Stan A van Belkum, MSc
Deputy Director, Medicines Evaluation Board, Netherlands
Have an account?